New Tech for Old Resolutions from Kintsu Spa

Happy New Year, and welcome to 2026, friends!

January is the month for new pledges and, as you can imagine, a MedSpa doctor receives more than her fair share of clients expressing a desire to make a fresh start, and to turn around the habits that negatively impact their skin quality, weight levels, and overall health in the new year. Unfortunately, as I’ve discussed here in the past, most of these resolutions melt away faster than the fat deposits they were designed to target in the first place! Maybe humans weren’t designed to jam major behavioral shifts into such short time frames.

When it comes to weight control, however, there might just be a few new tools that can help some people overcome the biggest hurdles.

You’ve probably heard of drugs like Ozempic and Wegovy, the GLP-1 receptor agonists designed to treat type 2 diabetes. The drugs themselves mimic your own naturally produced GLP-1, and their effectiveness at regulating blood sugar, slowing gastric emptying, and reducing appetites has led to an extension of their application and their use in chronic weight management. 

The use of these drugs is a reasonably complex issue that you can read about in more depth on my website (kintsuspa.com), but for today I’d like to discuss the practice of GLP-1 micro-dosing. Micro-dosing simply means using a much smaller fraction of the standard GLP-1 dose, often around a quarter, to provide gentler appetite regulation with fewer side effects.

Each full drug dose is a much higher concentration than that of your body’s innate levels, because it’s designed to provide the maximum effect on blood sugar regulation and weight loss. But not everyone can tolerate these levels, and not everyone requires such drastic shifts in their metabolism. This is where micro-dosing has shown promise.

Trials with much smaller doses have yielded real results, especially for users who don’t need the full therapeutic strength. For example, women entering menopause often find that hormonal changes lead to weight gain, brain fog, unpredictable energy levels, slower metabolism, and accelerated muscle breakdown. This loss in lean mass raises the risk of injuries and falls, making strength maintenance critically important. Yet the exercise required to rebuild strength is difficult to practice when you’re also struggling with all the other symptoms.

So what happens when perimenopause and menopause clients try just a quarter of the standard GLP-1 drug concentration? A significant percentage reported fewer cravings, less day-to-day appetite fluctuation, improved consistency with exercise routines, fewer late-night snacking urges, and feeling comfortable with smaller meal portions. Basically, for those seeking a gentle and adjustable approach to GLP-1 therapy—especially if they’re ready to pair it with lifestyle changes such as nutrition and strength training—micro-dosing can offer tangible results with fewer side effects.

Of course, the treatment still requires a professional prescription after a thorough medical assessment. For those curious about incorporating micro-dosing into their 2026 health strategy, you can easily start with a consultation. From there, the process is tailored to each individual, never rushed, and constantly monitored to see if adjustments are needed at any step along the journey.

I look forward to assisting anyone wishing to investigate this course, and wish all of you a wonderful New Year!